Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting

Blood (2025) 146 (Supplement 1): 5354.

https://doi.org/10.1182/blood-2025-5354

Published: 2025

Journal Articles

Intratumoral B cell diversity in follicular lymphoma revealed by single-cell paired transcriptome and BCR sequencing

Miranda Siminski, Janek Walker, Joseph Novak, Abigail Dropik, Zilin Xianyu, Zhi-Zhang Yang, Matthew Maurer, Thomas Habermann, Rebecca King, Thomas Witzig, Stephen Ansell, James Cerhan, Patrizia Mondello, Anne Novak

Blood (2025) 146 (Supplement 1): 5342.

https://doi.org/10.1182/blood-2025-5342

Published: 2025

Journal Articles

Bioflipi scores define distinct immune profiles in follicular lymphoma

Jordan Krull, Qin Ma, Emmanuel Contreras Guzman, Rebecca King, Andrew Feldman, Surendra Dasari, Diwakar Suresh, Jose Villasboas Bisneto, Matthew Maurer, Brian Link, Eric Hsi, Grzegorz Nowakowski, Thomas Habermann, Anne Novak, Melissa Larson, James Cerhan, Stephen Ansell, Patrizia Mondello

Blood (2025) 146 (Supplement 1): 5328.

https://doi.org/10.1182/blood-2025-5328

Published: 2025

Journal Articles

EO2463 (EO) peptide immunotherapy combined with rituximab (R) for first-line treatment of low-tumor burden follicular lymphoma (FL): A feasibility evaluation in Study EONHL1-20/sidney (NCT04669171)

Blood (2025) 146 (Supplement 1): 3594.

https://doi.org/10.1182/blood-2025-3594

Published: 2025

Journal Articles

Machine learning–driven prognostication of overall survival at 6 months after CAR-T cell therapy

Blood (2025) 146 (Supplement 1): 2563.

https://doi.org/10.1182/blood-2025-2563

Published: 2025

Journal Articles

NOTCH pathway activation is mediated by DTX1 loss of function mutations in DLBCL

Blood (2025) 146 (Supplement 1): 1771.

https://doi.org/10.1182/blood-2025-1771

Published: 2025

Journal Articles

Prognostic significance of cell-of-origin, gene expression profiles, and frontline therapy in predicting secondary CNS lymphoma in newly diagnosed diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 473.

https://doi.org/10.1182/blood-2025-473

Published: 2025

Journal Articles

Autologous stem cell transplantation and real-world outcomes in angioimmunoblastic T-cell lymphoma: A national cohort study

Yu Tao, Ayo Falade, Richard Godby, Steven Hwang, N. Nora Bennani, Stephen Ansell, Grzegorz Nowakowski, Yucai Wang, Jihao Zhou

Blood (2025) 146 (Supplement 1): 3640.

https://doi.org/10.1182/blood-2025-3640

Published: 2025

Journal Articles

Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma classification and subtyping

Blood (2025) 146 (Supplement 1): 117.

https://doi.org/10.1182/blood-2025-117

Published: 2025

Journal Articles

A national cancer database study of survival trends in patients with classical Hodgkin lymphoma: Improved survival in the novel agent era

Julia Wang, Steven Hwang, Urshila Durani, Gita Thanarajasingam, Arushi Khurana, Jonas Paludo, Yucai Wang, Grzegorz Nowakowski, Thomas Habermann, Thomas Witzig, Stephen Ansell, Jithma Abeykoon

Blood (2025) 146 (Supplement 1): 5399.

https://doi.org/10.1182/blood-2025-5399

Published: 2025

Journal Articles

Real-world outcomes of immune checkpoint inhibitor rechallenge in patients with classical Hodgkin lymphoma

Giuseppe Maiocco, Yoshito Nishimura, Guneet Janda, Yiqun Han, Urshila Durani, Grzegorz Nowakowski, Jonas Paludo, Stephen Ansell, Jithma Abeykoon

Blood (2025) 146 (Supplement 1): 5395.

https://doi.org/10.1182/blood-2025-5395

Published: 2025

Journal Articles

EO2463 (EO) peptide immunotherapy in patients (pts) with newly diagnosed asymptomatic follicular lymphoma (FL) and marginal zone lymphoma (MZL): Study EONHL1-20/sidney (NCT04669171) primary endpoint lugano objective response analysis

Blood (2025) 146 (Supplement 1): 5377.

https://doi.org/10.1182/blood-2025-5377

Published: 2025

Journal Articles

Frontline chemotherapy for CD30+ non-ALCL peripheral T-cell lymphoma a multi-center retrospective analysis

Blood (2025) 146 (Supplement 1): 3641.

https://doi.org/10.1182/blood-2025-3641

Published: 2025

Journal Articles

AI multimodal large language model on CAR-T pre-leukapheresis evaluation to predict monitoring needs post infusion for early dismissal planning

Blood (2025) 146 (Supplement 1): 6131.

https://doi.org/10.1182/blood-2025-6131

Published: 2025

Journal Articles

Metabolic pathway signatures unpinning response to CD19 CAR T-cell therapy in aggressive B-cell non-Hodgkin's lymphoma

Blood (2025) 146 (Supplement 1): 5894.

https://doi.org/10.1182/blood-2025-5894

Published: 2025

Journal Articles

Large language model for abstraction of CAR-T therapy toxicities data

Blood (2025) 146 (Supplement 1): 6139.

https://doi.org/10.1182/blood-2025-6139

Published: 2025

Journal Articles

Evolution of expert and healthcare professional treatment recommendations in the management of Mantle Cell Lymphoma

Amber Williams, Kristen Rosenthal, Stephen Ansell, Ian Flinn, Brad Kahl, Tycel Phillips, Julie Vose, Timothy Quill

Blood (2025) 146 (Supplement 1): 4650.

https://doi.org/10.1182/blood-2025-4650

Published: 2025

Journal Articles

Comparative immune profiling reveals T-cell exhaustion in EBV+ monomorphic PTLD vs. immunocompetent DLBCL

Aleksandr Lazaryan, Bin Yu, Christopher Cubitt, Hailing Zhang, Sean Yoder, Jose Villasboas Bisneto, Stephen Ansell, Jose Alejandro-Guevara

Blood (2025) 146 (Supplement 1): 3568.

https://doi.org/10.1182/blood-2025-3568

Published: 2025

Journal Articles

Tumor-derived microRNA-125a impairs CART cell function and predicts treatment failure in B cell malignancies

Blood (2025) 146 (Supplement 1): 2321.

https://doi.org/10.1182/blood-2025-2321

Published: 2025

Journal Articles

Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)

Blood (2025) 146 (Supplement 1): 5301.

https://doi.org/10.1182/blood-2025-5301

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting

Intratumoral B cell diversity in follicular lymphoma revealed by single-cell paired transcriptome and BCR sequencing

Bioflipi scores define distinct immune profiles in follicular lymphoma

EO2463 (EO) peptide immunotherapy combined with rituximab (R) for first-line treatment of low-tumor burden follicular lymphoma (FL): A feasibility evaluation in Study EONHL1-20/sidney (NCT04669171)

Machine learning–driven prognostication of overall survival at 6 months after CAR-T cell therapy

NOTCH pathway activation is mediated by DTX1 loss of function mutations in DLBCL

Prognostic significance of cell-of-origin, gene expression profiles, and frontline therapy in predicting secondary CNS lymphoma in newly diagnosed diffuse large B-cell lymphoma

Autologous stem cell transplantation and real-world outcomes in angioimmunoblastic T-cell lymphoma: A national cohort study

Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma classification and subtyping

A national cancer database study of survival trends in patients with classical Hodgkin lymphoma: Improved survival in the novel agent era

Real-world outcomes of immune checkpoint inhibitor rechallenge in patients with classical Hodgkin lymphoma

EO2463 (EO) peptide immunotherapy in patients (pts) with newly diagnosed asymptomatic follicular lymphoma (FL) and marginal zone lymphoma (MZL): Study EONHL1-20/sidney (NCT04669171) primary endpoint lugano objective response analysis

Frontline chemotherapy for CD30+ non-ALCL peripheral T-cell lymphoma a multi-center retrospective analysis

AI multimodal large language model on CAR-T pre-leukapheresis evaluation to predict monitoring needs post infusion for early dismissal planning

Metabolic pathway signatures unpinning response to CD19 CAR T-cell therapy in aggressive B-cell non-Hodgkin's lymphoma

Large language model for abstraction of CAR-T therapy toxicities data

Evolution of expert and healthcare professional treatment recommendations in the management of Mantle Cell Lymphoma

Comparative immune profiling reveals T-cell exhaustion in EBV+ monomorphic PTLD vs. immunocompetent DLBCL

Tumor-derived microRNA-125a impairs CART cell function and predicts treatment failure in B cell malignancies

Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only